PARAMETRIC PORTFOLIO ASSOCIATES LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 86 filers reported holding SERES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$190,000
-47.1%
26,654
-38.2%
0.00%
Q4 2021$359,000
-26.6%
43,156
-38.5%
0.00%
Q3 2021$489,000
-45.2%
70,198
+87.7%
0.00%
Q2 2021$892,000
+26.5%
37,406
+9.3%
0.00%
Q1 2021$705,000
+17.1%
34,231
+39.3%
0.00%
Q4 2020$602,000
-68.2%
24,581
-63.2%
0.00%
-100.0%
Q3 2020$1,892,000
+1517.1%
66,840
+171.7%
0.00%
Q2 2020$117,000
+46.2%
24,598
+9.2%
0.00%
Q1 2020$80,000
-66.5%
22,517
-67.6%
0.00%
Q4 2019$239,000
-12.8%
69,397
+1.4%
0.00%
Q3 2019$274,000
+552.4%
68,433
+427.7%
0.00%
Q2 2019$42,000
-90.4%
12,969
-52.4%
0.00%
Q3 2017$437,000
+76.9%
27,240
+24.4%
0.00%
Q2 2017$247,000
+2.9%
21,890
+2.6%
0.00%
Q1 2017$240,000
+15.4%
21,335
+1.3%
0.00%
Q4 2016$208,000
-62.2%
21,056
+11.2%
0.00%
-100.0%
Q2 2016$550,000
+12.2%
18,928
+2.6%
0.00%0.0%
Q1 2016$490,00018,4520.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders